Showing results (351-360 of 383) with videos related to
Sort By:
Pageof 39
Bone Marrow Transplantation|June 26, 1999
Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantationP Okunieff, A J Barrett, S E Phang, et al.Bone Marrow Transplantation|March 30, 2004
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host diseaseM R Robinson, S S Lee, B I Rubin, et al.Lancet (London, England)|November 15, 2000
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trialJ F Tisdale, D E Dunn, N Geller, et al.Lancet (London, England)|April 4, 1987
Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remissionR H Herzig, M M Bortin, A J Barrett, et al.Bone Marrow Transplantation|February 10, 2015
A multigene array for measurable residual disease detection in AML patients undergoing SCTM Goswami, K S McGowan, K Lu, et al.The Journal of Infectious Diseases|August 29, 2002
Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantationK Cortez, B R Murphy, K N Almeida, et al.Bone Marrow Transplantation|July 9, 2013
Active thrombopoiesis is associated with worse severity and activity of chronic GVHDT Bat, S M Steinberg, R Childs, et al.JAMA|August 5, 1992
Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980sM M Bortin, M M Horowitz, R P Gale, et al.The New England Journal of Medicine|September 14, 2000
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantationR Childs, A Chernoff, N Contentin, et al.British Journal of Haematology|November 28, 2001
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-backR Nakamura, E Bahceci, E J Read, et al.Pageof 39